With people of minority background and those with obesity and diabetes most at risk for severe cases of COVID-19, the National Institute of Diabetes and Digestive and Kidney Diseases is leading in the research behind why that is. Director Dr. Griffin Rodgers, who contributed to the first effective therapy for sickle cell anemia, updates HealthCast on the institute’s work to lessen the effects of COVID-19 on its research community, as well as other top research and data initiatives at the institution.
HealthCast
Season 2
Episode 17
21m listen
How One NIH Institute is Combating COVID-19 and Health Disparities
Share
NIDDK Director Dr. Griffin Rodgers talks COVID-19, disparities in health, and top priorities at the institute.
-
Dr. Griffin Rodgers Director NIDDK
Related Content
-
Coast Guard Software Yard Accelerates Secure Application Development
Coast Guard’s infrastructure official shared how the effort strengthens application development and cybersecurity.
8m watch -
5 Federal Tech Programs to Watch: AI, Weather Data and More
CDC, ARPA-H, the Pentagon, EPA and NASA are advancing programs that could reshape how emerging technologies support federal missions.
6m read -
VA EHR Rollout Brings ‘Interoperability at Its Best’ to Indiana
VA’s Indiana EHR rollout is helping clinicians share health data across facilities while supporting more connected care for veterans.
3m read -
VA Indiana EHR Deployments Show ‘Model Works’
VA deployed its EHR at three Indiana facilities as officials highlighted lessons learned, AI tools and preparations for future rollouts.
4m read
